TWF1 and neoplasm: Integrin-focused strategies are particularly promising due to their: tumor specificity (e.g., α6, αvβ3, and αvβ5), therapeutic synergy (e.g., immunotherapy and chemotherapy), delivery flexibility (e.g., EVs and liposomes), and regulatory depth (e.g., protease networks and actin-MT crosstalk).